FTSE All-Share
5.253,24
PKT
-12,50
PKT
-0,24
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.02.22 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 23.02.22 | HSBC Hold | Deutsche Bank AG | |
| 23.02.22 | HSBC Overweight | Barclays Capital | |
| 23.02.22 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 23.02.22 | Barclays Buy | Jefferies & Company Inc. | |
| 23.02.22 | BP Hold | Jefferies & Company Inc. | |
| 23.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.02.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 23.02.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 22.02.22 | HSBC Neutral | Credit Suisse Group | |
| 22.02.22 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 22.02.22 | Prudential Buy | UBS AG | |
| 22.02.22 | HSBC Buy | UBS AG | |
| 22.02.22 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.02.22 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 22.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 22.02.22 | HSBC Outperform | RBC Capital Markets | |
| 22.02.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 22.02.22 | HSBC Hold | Jefferies & Company Inc. | |
| 21.02.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 21.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 18.02.22 | GSK Neutral | UBS AG | |
| 18.02.22 | AstraZeneca Buy | UBS AG | |
| 18.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 16.02.22 | Prudential Buy | UBS AG | |
| 16.02.22 | AstraZeneca Buy | UBS AG | |
| 16.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.02.22 | Unilever Hold | Deutsche Bank AG | |
| 15.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.02.22 | AstraZeneca Overweight | Barclays Capital | |
| 15.02.22 | BAT Overweight | Barclays Capital | |
| 15.02.22 | Unilever Buy | Jefferies & Company Inc. | |
| 15.02.22 | BAT Neutral | JP Morgan Chase & Co. | |
| 15.02.22 | Unilever Sector Perform | RBC Capital Markets | |
| 15.02.22 | BAT Sector Perform | RBC Capital Markets | |
| 14.02.22 | BAT Buy | Deutsche Bank AG | |
| 14.02.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 14.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 14.02.22 | Unilever Sell | UBS AG | |
| 14.02.22 | Unilever Hold | Deutsche Bank AG |